Kanosamine (hydrochloride)
目录号 : GC14432
An antibiotic effective against plant pathogens
Cas No.:57649-10-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cell experiment: | MICs are determined by a serial dilution microtitrer plates method in Yeast Nitrogen Base medium containing 1% glucose or glycerol as a carbon source. Wells containing serially diluted kanosamine and control wells are inoculated with 105 cells /mL of an overnight culture of fungal cells and incubated for 24 h at 30°C. MIC is defined as the lowest antifungal agent concentration preventing visible growth. Alternatively, MICs are determined in RPMI 1640 medium buffered with 3-[N-morpholino]propanesulphonic acid (MOPS) to pH 7, under conditions recommended by NCCLS. In all cases, reproducible sharp end points are obtained and trailing effects are not observed[1]. |
References: [1]. Milner JL, et al. Production of kanosamine by Bacillus cereus UW85. Appl Environ Microbiol. 1996 Aug;62(8):3061-5. | |
Kanosamine is the antibiotic produced by Bacillus cereus UW85. Kanosamine showed highly inhibitory effects to the growth of plant-pathogenic oomycetes and moderately inhibitory effects to certain fungi and inhibited few bacterial species tested. Kanosamine accumulation in B. cereus UW85 culture supernatants was enhanced by the addition of ferric iron and suppressed by addition of phosphate to rich medium. Kanosamine accumulation was also enhanced more than 300% by the addition of alfalfa seedling exudate to minimal medium [1].
Kanosamine was also produced by a Streptomyces SP [2]. Kanosamine inhibited cell wall synthesis in plant-pathogenic oomycetes with MIC value of 25 μg/ml for P. medicaginis M2913 and certain fungi as well as some bacterial species with MIC value of 400 μg/ml for S. aureus [1,2]. It has been explored as an alternative and/or supplement to synthetic pesticides and genetic resistance of crop plants for the management of plant disease [1,2].
The antibiotic kanosamine inhibited the growth of many human pathogenic fungi. Kanosamine was transported into cells by the glucose transport system and subsequently phosphorylated to generate kanosamine-6-phosphate. The product was an inhibitor of the enzyme glucosamine-6-phosphate synthase. The Inhibitory effect was competitive to one of the substrates, D-fructose-6-phosphate, with Ki value of 5.9 mM. The action of kanosamine on C. albicans cells lead to profound morphological changes, inhibition of septum formation and cell agglutination [3].
References:
[1] Milner J L, Silo-Suh L, Lee J C, et al. Production of kanosamine by Bacillus cereus UW85[J]. Applied and Environmental Microbiology, 1996, 62(8): 3061-3065.
[2] Dolak L A, Castle T M, Dietz A, et al. 3-Amino-3-deoxyglucose produced by a Streptomyces SP[J]. The Journal of antibiotics, 1980, 33(8): 900-901.
[3] Janiak A M, Milewski S. Mechanism of antifungal action of kanosamine[J]. Medical mycology, 2001, 39(5): 401-408.
| Cas No. | 57649-10-2 | SDF | |
| 化学名 | 3-amino-3-deoxy-D-glucose, monohydrochloride | ||
| Canonical SMILES | O=C([H])[C@H](O)[C@@H](N)[C@H](O)[C@H](O)CO.Cl | ||
| 分子式 | C6H13NO5 • HCl | 分子量 | 215.6 |
| 溶解度 | ≤5mg/ml in ethanol;25mg/ml in DMSO;25mg/ml in dimethyl formamide | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 4.6382 mL | 23.1911 mL | 46.3822 mL |
| 5 mM | 0.9276 mL | 4.6382 mL | 9.2764 mL |
| 10 mM | 0.4638 mL | 2.3191 mL | 4.6382 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。